APA (7th ed.) Citation

Inoue, Y., Okamoto, H., Miyashita, A., Kawaji-Kanayama, Y., Chinen, S., Fujino, T., . . . Kuroda, J. (2024). Clinical impacts of severe thrombocytopenia in the first cycle of azacitidine monotherapy and cytogenetics in patients with myelodysplastic syndrome: The Kyoto Conditional Survival Scoring System. Oncology Letters, 27(2), N.PAG. https://doi.org/10.3892/ol.2023.14193

Chicago Style (17th ed.) Citation

Inoue, Yu, et al. "Clinical Impacts of Severe Thrombocytopenia in the First Cycle of Azacitidine Monotherapy and Cytogenetics in Patients with Myelodysplastic Syndrome: The Kyoto Conditional Survival Scoring System." Oncology Letters 27, no. 2 (2024): N.PAG. https://doi.org/10.3892/ol.2023.14193.

MLA (9th ed.) Citation

Inoue, Yu, et al. "Clinical Impacts of Severe Thrombocytopenia in the First Cycle of Azacitidine Monotherapy and Cytogenetics in Patients with Myelodysplastic Syndrome: The Kyoto Conditional Survival Scoring System." Oncology Letters, vol. 27, no. 2, 2024, p. N.PAG, https://doi.org/10.3892/ol.2023.14193.